Literature DB >> 12850840

Dynamic regulation of microtubule coils in ADP-induced platelet shape change by p160ROCK (Rho-kinase).

Benjamin Z S Paul1, Soochong Kim, Carol Dangelmaier, Chandrasekaran Nagaswami, Jianguo Jin, John H Hartwig, John W Weisel, James L Daniel, Satya P Kunapuli.   

Abstract

Platelet shape change is an extremely rapid process mediated by both the calcium-sensitive and p160ROCK pathways. The present study examines how different features of shape change studied by scanning electron microscopy clearly correlate to changes in the pattern of light absorbance measured in an aggregometer. Platelets change shape from the initial 'disc' form by producing: membrane 'blebs', sphere formation (cell-rounding), filopodia extension, and surface membrane folding. The presentation of these features was dramatically slower in the absence of intracellular calcium mobilization. In the presence of the p160ROCK-inhibitor, Y-27632, shape change was initially normal but platelets rapidly transformed back to smooth discs with extended filopodia. The reappearance of the disc shape is reflected by an increase in the amplitude of oscillations in the aggregometer shape change tracing. The kinetics of actin/cytoskeleton association correlated with filopodia formation but not with disc to sphere transformation. Changes in the level of tubulin polymerization correlated with changes from disc to sphere morphology. These experiments are consistent with a role for a RhoA/Rho kinase-regulated pathway in the maintenance of a spherical platelet shape after agonist-dependent activation. Continued disruption of the cytoskeletal microtubule ring, appears to be a Rhokinase-dependent event involved in the transformation of discoid platelets into spheres.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850840     DOI: 10.1080/0953710031000092794

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

Review 1.  Central role of the P2Y12 receptor in platelet activation.

Authors:  Robert T Dorsam; Satya P Kunapuli
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.

Authors:  Susanne Horner; Kirsten Menke; Caren Hildebrandt; Matthias U Kassack; Peter Nickel; Heiko Ullmann; Martyn P Mahaut-Smith; Günter Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-09-13       Impact factor: 3.000

3.  Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition.

Authors:  Giuliana Gobbi; Prisco Mirandola; Cecilia Carubbi; Elena Masselli; Stephen M Sykes; Francesca Ferraro; Antonio Nouvenne; Jonathan N Thon; Joseph E Italiano; Marco Vitale
Journal:  Blood       Date:  2013-07-09       Impact factor: 22.113

4.  Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase.

Authors:  Soochong Kim; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

5.  Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.

Authors:  Benjamin Aj Reddi; Samantha M Iannella; Stephanie N O'Connor; Adam M Deane; Scott R Willoughby; David P Wilson
Journal:  Intensive Care Med Exp       Date:  2015-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.